The diabetic foot

QJM: An International Journal of Medicine

Volumn 101, Issue 9, 2008, Pages 685-695

  Khanolkar, M P ^a   Bain, S C ^b   Stephens, J W ^a,b  

^a MORRISTON HOSPITAL   (United Kingdom)

^b SWANSEA UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; ANTIBIOTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; HYALURONIC ACID; PAMIDRONIC ACID; PROMOGRAN; WOUND HEALING PROMOTING AGENT;

CAST APPLICATION; CLINICAL TRIAL; DEBRIDEMENT; DIABETIC FOOT; DIABETIC NEUROPATHY; DRUG POTENCY; FOOT AMPUTATION; FOOT CARE; FOOT SURGERY; FOOT ULCER; HUMAN; INCIDENCE; MAGGOT THERAPY; NEUROLOGIC EXAMINATION; NEUROPATHIC JOINT DISEASE; OSTEOMYELITIS; PATHOGENESIS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RISK REDUCTION; VACUUM ASSISTED CLOSURE; WOUND ASSESSMENT; WOUND DRESSING; WOUND INFECTION;

EID: 51049092501     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcn027     Document Type: Review

References (91)

1. Rathur HM, Boulton AJ. The diabetic foot. Clin Dermatol 2007; 25:109-20.
2. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. Jama 2005; 293:217-28.
3. Jeffcoate W, Bakker K. World Diabetes Day: Footing the bill. Lancet 2005; 365:1527.
4. Tentolouris N, Al-Sabbagh S, Walker MG, Boulton AJ, Jude EB. Mortality in diabetic and nondiabetic patients after amputations performed from 1990 to 1995: A 5-year follow-up study. Diabetes Care 2004; 27 1598-604.
5. Vileikyte L. Diabetic foot ulcers: A quality of life issue. Diabetes Metab Res Rev 2001; 17:246-49.
6. Meltzer DD, Pels S, Payne WG, Mannari RJ, Ochs D, Forbes-Kearns J, et al. Decreasing amputation rates in patients with diabetes mellitus. An outcome study. J Am Podiatr Med Assoc 2002; 92:425-28.
7. Abbott CA, Carrington AL, Ashe H, Bath S, Every LC, Griffiths J, et al. The North-West Diabetes Foot Care Study: Incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med 2002; 19:377-84.
8. Abbott CA, Garrow AP, Carrington AL, Morris J, Van Ross ER, Boulton AJ. Foot ulcer risk is lower in South-Asian and African-Caribbean compared with European diabetic patients in the U.K.: The North-West diabetes foot care study. Diabetes Care 2005; 28:1869-875.
9. Siitonen OI, Niskanen LK, Laakso M, Siitonen JT, Pyorala K. Lower-extremity amputations in diabetic and nondiabetic patients. A population-based study in eastern Finland. Diabetes Care 1993; 16:16-20.
10. Trautner C, Haastert B, Giani G, Berger M. Incidence of lower limb amputations and diabetes. Diabetes Care 1996; 19:1006-009.
11. Reiber GE, Vileikyte L, Boyko EJ, del Aguila M, Smith DG, Lavery LA, Boulton AJ. Causal pathways for in.cident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care 1999; 22:157-62.
12. Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993; 36 150-54.
13. Young MJ, Breddy JL, Veves A, Boulton AJ. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study. Diabetes Care 1994; 17:597-60.
14. Urbancic-Rovan V. Causes of diabetic foot lesions. Lancet 2005; 366:1675-676.
15. Cavanagh PR, Young MJ, Adams JE, Vickers KL, Boulton AJ. Radiographic abnormalities in the feet of patients with diabetic neuropathy. Diabetes Care 1994; 17:201-09.
16. Brower AC, Allman RM. Pathogenesis of the neurotrophic joint: neurotraumatic vs. neurovascular. Radiology 1981; 139:349-54.
17. Edmonds ME, Clarke MB, Newton S, Barrett J, Watkins PJ. Increased uptake of bone radiopharmaceutical in diabetic neuropathy. Q J Med 1985; 57:843-55.
18. Young MJ, Marshall A, Adams JE, Selby PL, Boulton AJ. Osteopenia, neurological dysfunction, and the development of Charcot neuroarthropathy. Diabetes Care 1995; 18:34-8.
19. Cavanagh PR, Lipsky BA, Bradbury AW, Botek G. Treatment for diabetic foot ulcers. Lancet 2005; 366:1725-735.
20. Lobmann R, Ambrosch A, Schultz G, Waldmann K, Schiweck S, Lehnert H. Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and nondiabetic patients. Diabetologia 2002; 45:1011-016.
21. Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol 1999; 26:259-65.
22. Gupta AK, Humke S. The prevalence and management of onychomycosis in diabetic patients. Eur J Dermatol 2000; 10:379-84.
23. Lemaster JW, Reiber GE, Smith DG, Heagerty PJ, Wallace C. Daily weight-bearing activity does not increase the risk of diabetic foot ulcers. Med Sci Sports Exerc 2003; 35:1093-99.
24. Armstrong DG. The 10-g monofilament: The diagnostic divining rod for the diabetic foot? Diabetes Care 2000; 23:887.
25. Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Davignon DR, Smith DG. A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study. Diabetes Care 1999; 22:1036-42.
26. Rith-Najarian SJ, Stolusky T, Gohdes DM. Identifying diabetic patients at high risk for lower-extremity amputation in a primary health care setting. A prospective evaluation of simple screening criteria. Diabetes Care 1992; 15:1386-389.
27. Pham H, Armstrong DG, Harvey C, Harkless LB, Giurini JM, Veves A. Screening techniques to identify people at high risk for diabetic foot ulceration: A prospective multicenter trial. Diabetes Care 2000; 23:606-11.
28. Smieja M, Hunt DL, Edelman D, Etchells E, Cornuz J, Simel DL. Clinical examination for the detection of protective sensation in the feet of diabetic patients. International Cooperative Group for Clinical Examination Research. J Gen Intern Med 1999; 14:418-24.
29. Bus SA, Ulbrecht JS, Cavanagh PR. Pressure relief and load redistribution by custom-made insoles in diabetic patients with neuropathy and foot deformity. Clin Biomech (Bristol, Avon) 2004; 19:629-38.
30. Boulton AJM. Cavanagh PR, Rayman G. The Foot in Diabetes, 4th edn. John Wiley & Sons, Ltd., 2006.
31. Sinha S, Munichoodappa CS, Kozak GP. Neuro-arthropathy (Charcot joints) in diabetes mellitus (clinical study of 101 cases). Medicine (Baltimore) 1972; 51:191-210.
32. Fowkes FG. The measurement of atherosclerotic peripheral arterial disease in epidemiological surveys. Int J Epidemiol 1988; 17 248-54.
33. Feigelson HS, Criqui MH, Fronek A, Langer RD, Molgaard CA. Screening for peripheral arterial disease: The sensitivity, specificity, and predictive value of noninvasive tests in a defined population. Am J Epidemiol 1994; 140:526-34.
34. Chew JT, Tan SB, Sivathasan C, Pavanni R, Tan SK. Vascular assessment in the neuropathic diabetic foot. Clin Orthop Relat Res 1995; 320 95-100.
35. Brooks B, Dean R, Patel S, Wu B, Molyneaux L, Yue DK. TBI or not TBI: that is the question. Is it better to measure toe pressure than ankle pressure in diabetic patients? Diabet Med 2001; 18:528-32.
36. Williams DT, Harding KG, Price P. An evaluation of the efficacy of methods used in screening for lower-limb arterial disease in diabetes. Diabetes Care 2005; 28:2206-10.
37. Edmonds ME. Progress in care of the diabetic foot. Lancet 1999; 354:270-72.
38. Oyibo SO, Jude EB, Tarawneh I, Nguyen HC, Harkless LB, Boulton AJ. A comparison of two diabetic foot ulcer classification systems: The Wagner and the University of Texas wound classification systems. Diabetes Care 2001; 24:84-8.
39. Schaper NC. Diabetic foot ulcer classification system for research purposes: A progress report on criteria for including patients in research studies. Diabetes Metab Res Rev 2004; 20(Suppl. 1) S90-5.
40. Heggers JP. Defining infection in chronic wounds: Does it matter? J Wound Care 1998; 7:389-92.
41. Pittet D, Wyssa B, Herter-Clavel C, Kursteiner K, Vaucher J, Lew PD. Outcome of diabetic foot infections treated conservatively: A retrospective cohort study with long-term follow-up. Arch Intern Med 1999; 159:851-56.
42. Lipsky BA, Berendt AR, Deery HG, Embil JM, Joseph WS, Karchmer AW, et al. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2004; 39:885-910.
43. El-Tahawy AT. Bacteriology of diabetic foot. Saudi Med J 2000; 21:344-47.
44. Abdulrazak A, Bitar ZI, Al-Shamali AA, Mobasher LA. Bacteriological study of diabetic foot infections. J Diabetes Complications 2005; 19:138-41.
45. Goldstein EJ, Citron DM, Nesbit CA. Diabetic foot infections. Bacteriology and activity of 10 oral antimicrobial agents against bacteria isolated from consecutive cases. Diabetes Care 1996; 19:638-41.
46. Gerding DN, Foot infections in diabetic patients: The role of anaerobes. Clin Infect Dis 1995; 20(Suppl. 2): S283-88.
47. Cunha BA. Antibiotic selection for diabetic foot infections: A review. J Foot Ankle Surg 2000; 39:253-57.
48. Soysal N, Ayhan M, Guney E, Akyol A. Differential diagnosis of Charcot arthropathy and osteomyelitis. Neuro Endocrinol Lett 2007; 28 556-59.
49. McIntosh A, Peters J, Young R, Hutchinson A, Chiverlon R, Clarkson S, et al. Type 2 diabetes: Prevention and management of foot problems. Nice clinical guideline 10 2004; 10:45-6.
50. Delamaire M, Maugendre D, Moreno M, Le Goff MC, Allannic H, Genetet B. Impaired leucocyte functions in diabetic patients. Diabet Med 1997; 14:29-34.
51. Young MJ, Cavanagh PR, Thomas G, Johnson MM, Murray H, Boulton AJ. The effect of callus removal on dynamic plantar foot pressures in diabetic patients. Diabet Med 1992; 9:55-7.
52. Hobbs SD, Bradbury AW. Smoking cessation strategies in patients with peripheral arterial disease: An evidence-based approach. Eur J Vasc Endovasc Surg 2003; 26:341-47.
53. Prisant LM. Clinical trials and lipid guidelines for type II diabetes. J Clin Pharmacol 2004; 44:423-30.
54. Hirsh J, Bhatt DL. Comparative benefits of clopidogrel and aspirin in high-risk patient populations: Lessons from the CAPRIE and CURE studies. Arch Intern Med 2004; 164:2106-10.
55. Whaley-Connell A, Sowers JR. Hypertension management in type 2 diabetes mellitus: Recommendations of the Joint National Committee VII. Endocrinol Metab Clin North Am 2005; 34:63-75.
56. Bates MC, Aburahma AF. An update on endovascular therapy of the lower extremities. J Endovasc Ther 2004; 11(Suppl. 2):II107-127.
57. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 2000; 31:S1-296.
58. Dorrucci V. Treatment of superficial femoral artery occlusive disease. J Cardiovasc Surg (Torino) 2004; 45:193-201.
59. Gibbons GW. Lower extremity bypass in patients with diabetic foot ulcers. Surg Clin North Am 2003; 83:659-69.
60. Lauterbach SR, Torres GA, Andros G, Oblath RW. Infragenicular polytetrafluoroethylene bypass with distal vein cuffs for limb salvage: a contemporary series. Arch Surg 2005; 140:487-93; discussion 493-4.
61. Bradbury A, Wilmink T, Lee AJ, Bell J, Prescott R, Gillespie I, et al Bypass versus angioplasty to treat severe limb ischemia: Factors that affect treatment preferences of UK surgeons and interventional radiologists. J Vasc Surg 2004; 39:1026-32.
62. Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 2005; 366 1925-34.
63. Grayson ML, Gibbons GW, Balogh K, Levin E, Karchmer AW. Probing to bone in infected pedal ulcers. A clinical sign of underlying osteomyelitis in diabetic patients. Jama 1995; 273:721-23.
64. Lipsky BA, Berendt AR. Principles and practice of antibiotic therapy of diabetic foot infections. Diabetes Metab Res Rev 2000; 16(Suppl. 1):S42-6.
65. Jeffcoate WJ, Lipsky BA. Controversies in diagnosing and managing osteomyelitis of the foot in diabetes. Clin Infect Dis 2004; 39(Suppl. 2):S115-22.
66. Ha Van G, Siney H, Danan JP, Sachon C, Grimaldi A. Treatment of osteomyelitis in the diabetic foot. Contribution of conservative surgery. Diabetes Care 1996; 19:1257-60.
67. Armstrong DG, Nguyen HC, Lavery LA, van Schie CH, Boulton AJ, Harkless LB. Off-loading the diabetic foot wound: A randomized clinical trial. Diabetes Care 2001; 24:1019-22.
68. Mueller MJ, Diamond JE, Sinacore DR, Delitto A, Blair VP, 3rd, Drury DA, et al. Total contact casting in treatment of diabetic plantar ulcers. Controlled clinical trial. Diabetes Care 1989; 12 384-88.
69. Ha Van G, Siney H, Hartmann-Heurtier A, Jacqueminet S, Greau F, Grimaldi A. Nonremovable, windowed, fiberglass cast boot in the treatment of diabetic plantar ulcers: Efficacy, safety, and compliance. Diabetes Care 2003; 26:2848-52.
70. Armstrong DG, Lavery LA, Wu S, Boulton AJ. Evaluation of removable and irremovable cast walkers in the healing of diabetic foot wounds: A randomized controlled trial. Diabetes Care 2005; 28:551-54.
71. Lavery LA, Vela SA, Lavery DC, Quebedeaux TL. Reducing dynamic foot pressures in high-risk diabetic subjects with foot ulcerations. A comparison of treatments. Diabetes Care 1996; 19: 818-21.
72. Knowles EA, Armstrong DG, Hayat SA, Khawaja KI, Malik RA, Boulton AJ. Offloading diabetic foot wounds using the scotchcast boot: A retrospective study. Ostomy Wound Manage 2002; 48:50-3.
73. Hess CT, Kirsner RS. Orchestrating wound healing: Assessing and preparing the wound bed. Adv Skin Wound Care 2003; 16 246-57; quiz 258-9.
74. Steed DL, Donohoe D, Webster MW, Lindsley L. Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. Diabetic Ulcer Study Group. J Am Coll Surg 1996; 183:61-4.
75. Armstrong DG, Mossel J, Short B, Nixon BP, Knowles EA, Boulton AJ. Maggot debridement therapy: A primer. J Am Podiatr Med Assoc 2002; 92:398-401.
76. Bowling FL, Salgami EV, Boulton AJ. Larval therapy: A novel treatment in eliminating methicillin-resistant Staphylococcus aureus from diabetic foot ulcers. Diabetes Care 2007; 30:370-71.
77. Blackman JD, Senseng D, Quinn L, Mazzone T. Clinical evaluation of a semipermeable polymeric membrane dressing for the treatment of chronic diabetic foot ulcers. Diabetes Care 1994; 17:322-25.
78. Leigh R, Barker S, Murray N, Hurel SJ. The Kerraboot: A novel wound dressing device for the management of leg and foot ulcers. Practical Diabetes International 2004; 21:27-30.
79. Cullen B, Smith R, McCulloch E, Silcock D, Morrison L. Mechanism of action of PROMOGRAN, a protease modulating matrix, for the treatment of diabetic foot ulcers. Wound Repair Regen 2002; 10: 16-25.
80. Veves A, Sheehan P, Pham HT. A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers. Arch Surg 2002; 137: 822-7.
81. Vazquez JR, Short B, Findlow AH, Nixon BP, Boulton AJ, Armstrong DG. Outcomes of hyaluronan therapy in diabetic foot wounds. Diabetes Res Clin Pract 2003; 59: 123-27.
82. Donaghue VM, Chrzan JS, Rosenblum BI, Giurini JM, Habershaw GM, Veves A. Evaluation of a collagen-alginate wound dressing in the management of diabetic foot ulcers. Adv Wound Care 1998; 11: 114-19.
83. Armstrong DG, Lavery LA, Abu-Rumman P, Espensen EH, Vazquez JR, Nixon BP, et al. Outcomes of subatmospheric pressure dressing therapy on wounds of the diabetic foot. Ostomy Wound Manage 2002; 48 64-8.
84. Armstrong DG, Lavery LA. Negative pressure wound therapy after partial diabetic foot amputation: A multicentre, randomised controlled trial. Lancet 2005; 366:1704-10.
85. Tyrrell W. Orthotic intervention in patients with diabetic foot ulceration. J Wound Care 1999; 8:530-32.
86. Armstrong DG, Frykberg RG. Classifying diabetic foot surgery: Toward a rational definition. Diabet Med 2003; 20:329-31.
87. Maluf KS, Mueller MJ, Strube MJ, Engsberg JR, Johnson JE. Tendon Achilles lengthening for the treatment of neuropathic ulcers causes a temporary reduction in forefoot pressure associated with changes in plantar flexor power rather than ankle motion during gait. J Biomech 2004; 37:897-906.
88. Coughlin MJ. Lesser toe abnormalities. Instr Course Lect 2003; 52:421-44.
89. Fleischli JE, Anderson RB, Davis WH. Dorsiflexion metatarsal osteotomy for treatment of recalcitrant diabetic neuropathic ulcers. Foot Ankle Int 1999; 20:80-5.
90. Pinzur M. Surgical versus accommodative treatment for Charcot arthropathy of the midfoot. Foot Ankle Int 2004; 25:545-49.
91. Jude EB, Selby PL, Burgess J, Lilleystone P, Mawer EB, Page SR, et al Bisphosphonates in the treatment of Charcot neuroarthropathy: A double-blind randomised controlled trial. Diabetologia 2001; 44 2032-37.